Thursday, February 16, 2017

Xcell Biosciences Finds $12M

San Francisco-based Xcell Biosciences announced that it has raised $12M in a Series A funding round, the company said this morning. The funding was led by HBM Genomics, and also included its other major existing investors. HBM Managing Director Saeid Akhtari will join the company's board with the funding. The company is developing a system which automated cell culture, in order to maintain key physiological conditions found in cellular microenvironments.